In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines
2007

Inhibition of the CXCR4/CXCL12 Axis in Uveal Melanoma

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Di Cesare Sebastian, Marshall Jean-Claude, Fernandes Bruno F, Logan Patrick, Antecka Emilia, Filho Vasco Bravo, Burnier Miguel N Jr

Primary Institution: McGill University Health Center

Hypothesis

The CXCR4/CXCL12 chemokine axis plays a critical role in guiding CXCR4+ circulating malignant cells to specific organs, and inhibiting this axis with TN14003 can reduce cell migration in uveal melanoma.

Conclusion

Using TN14003 to interfere with the CXCR4/CXCL12 axis effectively reduced uveal melanoma cell migration in vitro.

Supporting Evidence

  • All five uveal melanoma cell lines expressed the CXCR4 receptor.
  • TN14003 did not significantly affect the proliferation of the cell lines.
  • All cell lines migrated towards CXCL12 at a level greater than the negative control.
  • Pre-incubation with TN14003 prevented cellular migration towards CXCL12.

Takeaway

This study found that a special drug can stop cancer cells from moving to other parts of the body, which might help treat eye cancer.

Methodology

The study used immunocytochemistry, flow cytometry, proliferation assays, and migration assays to evaluate the effects of TN14003 on uveal melanoma cell lines.

Limitations

The study was conducted in vitro, and further in vivo studies are needed to confirm the findings.

Participant Demographics

Five human uveal melanoma cell lines were used in the study.

Statistical Information

P-Value

p < 0.01

Statistical Significance

p < 0.01

Digital Object Identifier (DOI)

10.1186/1475-2867-7-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication